ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2433

Transcriptome Analysis in Women with Rheumatoid Arthritis Who Improve or Worsen during Pregnancy

Dana E. Goin1,2, Mette Smed3, Lior Pachter2,4, Elizabeth Purdom2, J. Lee Nelson5,6, Hanne Kjaergaard3, Jørn Olsen7, Merete Lund Hetland8,9, Bent Ottesen3, Vibeke Zoffmann3 and Damini Jawaheer1,7,10, 1UCSF Benioff Children's Hospital Oakland/CHORI, Oakland, CA, 2University of California, Berkeley, Berkeley, CA, 3Juliane Marie Center, Copenhagen, Denmark, 4California Institute of Technology, Pasadena, CA, 5Immunogenetics, Fred Hutchinson Cancer Rsch, Seattle, WA, 6University of Washington, Seattle, WA, 7Aarhus University, Aarhus, Denmark, 8The DANBIO registry and the Danish Departments of Rheumatology, Glostrup, Denmark, 9University of Copenhagen, Copenhagen, Denmark, 10University of California, San Francisco, San Francisco, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Gene Expression, pregnancy and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Gene expression changes induced by pregnancy in women with rheumatoid arthritis (RA) and healthy women have not been examined. The few studies previously conducted did not have pre-pregnancy samples available as baseline. We have established a cohort of RA and healthy women followed prospectively from pre-pregnancy. In this study, we aimed to identify pregnancy-induced changes in gene expression among women with RA and healthy women, and to assess how those changes may differ between RA women who improve or worsen during pregnancy.

Methods: Clinical data and samples collected from a subset of 11 women with RA and 5 healthy women from our cohort before pregnancy (T0) and at the third trimester (T3) were analyzed. Disease activity scores were used to determine whether the RA women improved or worsened during pregnancy. Global gene expression profiles were generated by RNA sequencing (RNA-seq). The raw RNA-seq reads were pseudo-aligned to the reference transcriptome and expression levels were estimated with kallisto. Differential expression analysis of normalized expression levels was performed using edgeR to identify genes differentially expressed within each group of women (T3 vs T0), using a fold-change cut-off of 2 and a significance threshold of q<0.05 (FDR-adjusted). Functional enrichment analysis was performed using WebGestalt.

Results: Of the 11 women with RA, 8 showed an improvement in disease activity by T3 (RAimproved), while 3 worsened (RAworsened). In the RAimproved group, a total of 161 genes were differentially expressed (DE) between T3 and T0. These included several genes whose expression have previously been associated with RA (e.g. S100A12, SLC14A1) as well as genes involved in the innate immune system (e.g. type I interferon-inducible genes). The majority of these genes (108 of 161) were also DE among healthy women. Of interest, most genes (30 of 31) that were significantly DE in both of the RA groups were also DE among healthy women (e.g. α-defensin genes). There were also differences between the RAimproved and RAworsened groups. A set of IFN-inducible genes was over-expressed at T3 (vs T0) in the RAimproved but not the RAworsened women. Additionally, some interesting candidate genes whose expression have previously been associated with RA (e.g. MMP9, PADI4 and PGLYRP1) were over-expressed at T3 (vs. T0) among RAworsened but not among RAimproved women.

Conclusion: Pregnancy-induced gene expression changes common between RA women who improved and those who worsened appeared to be normal pregnancy-related changes that were also observed among healthy women. Other genes that demonstrated different patterns of expression between the two RA groups are potential candidates that could be involved in the natural pregnancy-induced amelioration of RA.


Disclosure: D. E. Goin, None; M. Smed, None; L. Pachter, None; E. Purdom, None; J. L. Nelson, None; H. Kjaergaard, None; J. Olsen, None; M. Lund Hetland, None; B. Ottesen, None; V. Zoffmann, None; D. Jawaheer, None.

To cite this abstract in AMA style:

Goin DE, Smed M, Pachter L, Purdom E, Nelson JL, Kjaergaard H, Olsen J, Lund Hetland M, Ottesen B, Zoffmann V, Jawaheer D. Transcriptome Analysis in Women with Rheumatoid Arthritis Who Improve or Worsen during Pregnancy [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/transcriptome-analysis-in-women-with-rheumatoid-arthritis-who-improve-or-worsen-during-pregnancy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptome-analysis-in-women-with-rheumatoid-arthritis-who-improve-or-worsen-during-pregnancy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology